Prognostic Role of 14F7 Mab Immunoreactivity against N-Glycolyl GM3 Ganglioside in Colon Cancer

@inproceedings{Lahera2014PrognosticRO,
  title={Prognostic Role of 14F7 Mab Immunoreactivity against N-Glycolyl GM3 Ganglioside in Colon Cancer},
  author={Tania Lahera and Adanays Calvo and Griselda Torres and Charles E. Rengifo and Santiago Osorno Quintero and Mar{\'i}a del Carmen Arango and Debora Danta and Jos{\'e} M. V{\'a}zquez and Xiomara Escobar and Adriana Carr},
  booktitle={Journal of oncology},
  year={2014}
}
Purpose. To assess the prognostic role of 14F7 Mab immunoreactivity, against N-Glycolyl GM3 ganglioside, in patients with colon cancer (CC) and to evaluate the relationship between its expression and clinicopathological features. Methods. Paraffin-embedded specimens were retrospectively collected from 50 patients with CC operated between 2004 and 2008. 14F7 Mab staining was determined by immunohistochemistry technique and its relation with survival and clinicopathologic features was evaluated… CONTINUE READING
6 Citations
37 References
Similar Papers

References

Publications referenced by this paper.
Showing 1-10 of 37 references

Amouse IgG1monoclonal antibody specific for N-glycolyl GM3 ganglioside recognized breast and melanoma tumors

  • A. Carr, A.Mullet, Z.Mazorra
  • Hybridoma, vol. 19, no. 3, pp. 241–247, 2000.
  • 2000
Highly Influential
4 Excerpts

Immunorecognition of the 14F7 Mab raised against N-Glycolyl GM3 ganglioside in somenormal andmalignant tissues fromgenitourinary system

  • R. Blanco, M. Cedeño, X. Escobar
  • ISRN Pathology, vol. 2011, Article ID 953803, 10…
  • 2011
1 Excerpt

Similar Papers

Loading similar papers…